605507 國邦醫藥
按盤價 
24.250 -1.610 (-6.226%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.861 | 9.889 | 10.099 | 8.397 | 13.642 |
| 總資產報酬率 ROA (%) | 1.435 | 7.543 | 7.394 | 6.312 | 11.125 |
| 投入資產回報率 ROIC (%) | 1.536 | 8.081 | 7.962 | 6.816 | 11.966 | 邊際利潤分析 |
| 銷售毛利率 (%) | 23.064 | 26.032 | 25.000 | 23.410 | 27.549 |
| 營業利潤率 (%) | 12.357 | 16.036 | 15.194 | 13.128 | 18.404 |
| 息稅前利潤/營業總收入 (%) | 13.801 | 16.168 | 14.568 | 12.176 | 16.914 |
| 淨利潤/營業總收入 (%) | 10.529 | 13.600 | 13.251 | 11.403 | 16.092 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.356 | 95.684 | 99.521 | 99.567 | 101.981 |
| 價值變動淨收益/利潤總額(%) | 3.814 | 3.145 | 3.080 | 3.378 | 2.327 |
| 營業外收支淨額/利潤總額(%) | -0.410 | -1.339 | -0.799 | -0.661 | -1.665 | 償債能力分析 |
| 流動比率 (X) | 2.540 | 3.182 | 2.297 | 2.222 | 2.754 |
| 速動比率 (X) | 1.863 | 2.257 | 1.764 | 1.663 | 1.998 |
| 資產負債率 (%) | 23.518 | 22.113 | 25.309 | 28.224 | 20.884 |
| 帶息債務/全部投入資本 (%) | 18.187 | 16.141 | 19.932 | 21.962 | 14.692 |
| 股東權益/帶息債務 (%) | 448.511 | 517.736 | 400.511 | 354.226 | 578.533 |
| 股東權益/負債合計 (%) | 325.127 | 352.114 | 294.950 | 254.135 | 378.870 |
| 利息保障倍數 (X) | 9.236 | 47.067 | -28.781 | -14.074 | -14.227 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 55.512 | 48.307 | 39.299 | 40.360 | 34.998 |
| 存貨周轉天數 (天) | 135.244 | 127.093 | 111.304 | 122.036 | 118.058 |
| 備註： | 即時報價更新時間為 16/04/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
